Takeda Pharmaceutical Company's market cap is currently $44.45B. The company's EPS TTM is $0.432; its P/E ratio is 32.15; and it has a dividend yield of 3.68%. Takeda Pharmaceutical Company is scheduled to report earnings on January 30, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	¥ 4.26T	¥ 4.03T	¥ 3.57T	¥ 3.20T	¥ 3.29T
Gross Profit	¥ 2.83T	¥ 2.78T	¥ 2.46T	¥ 2.20T	¥ 2.20T
Operating Income	¥ 214.07B	¥ 490.50B	¥ 460.84B	¥ 509.27B	¥ 100.41B
EBITDA	¥ 874.60B	¥ 1.16T	¥ 1.18T	¥ 983.72B	¥ 880.33B
Net Income	¥ 144.07B	¥ 317.02B	¥ 230.06B	¥ 376.00B	¥ 44.24B
Balance Sheet
Cash & Short-Term Investments	¥ 457.80B	¥ 553.70B	¥ 875.00B	¥ 1.00T	¥ 653.44B
Total Assets	¥ 15.11T	¥ 13.96T	¥ 13.18T	¥ 12.91T	¥ 12.82T
Total Debt	¥ 4.84T	¥ 4.38T	¥ 4.35T	¥ 4.64T	¥ 5.09T
Net Debt	¥ 4.39T	¥ 3.85T	¥ 3.50T	¥ 3.67T	¥ 4.46T
Total Liabilities	¥ 7.83T	¥ 7.60T	¥ 7.49T	¥ 7.74T	¥ 8.09T
Stockholders' Equity	¥ 7.27T	¥ 6.35T	¥ 5.68T	¥ 5.17T	¥ 4.72T
Cash Flow
Free Cash Flow	¥ 235.61B	¥ 343.47B	¥ 937.07B	¥ 774.46B	¥ 452.04B
Operating Cash Flow	¥ 716.34B	¥ 977.16B	¥ 1.12T	¥ 1.01T	¥ 669.75B
Investing Cash Flow	¥ -463.86B	¥ -607.10B	¥ -198.13B	¥ 393.53B	¥ 292.12B
Financing Cash Flow	¥ -354.42B	¥ -709.15B	¥ -1.07T	¥ -1.09T	¥ -1.01T

Currency in JPY

Takeda Pharmaceutical Company Earnings and Revenue History

Income Statement >

Takeda Pharmaceutical Company Debt to Assets

Balance Sheet >

Takeda Pharmaceutical Company Cash Flow

Cash Flow >

Takeda Pharmaceutical Company Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing